Tepnel Life Sciences plc Expands Genetic Services Portfolio with Addition of Illumina iScan Rapid Reader.
Tepnel Life Sciences plc announced that it has expanded its molecular genetic services offering through the addition of Illumina's iScan System, a next-generation scanner that provides researchers conducting genetic variation studies with significantly greater throughput and application diversity. This marks the first anniversary of Tepnel's new pharmaceutical services facility and makes Tepnel the first commercial provider of iScan services within the UK. Combined with Tepnel's established range of upstream and downstream genetic capabilities, the Company now offers a full suite of complementary services from DNA extraction through to Bioinformatics.
